Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

05 janv. 2015 01h33 HE | Source: Dignity Sciences Limited

Positive Pre-Clinical Results for Non-Alcoholic Steatohepatitis (NASH) with Anti-fibrotic DS102 Bioactive Lipid

DUBLIN, Ireland, Jan. 5, 2015 (GLOBE NEWSWIRE) -- via PRWEB - DS102 was tested in an In Vivo Efficacy STAM™ model, an indication specific standard for NASH, over two different time periods, all...
30 juil. 2014 01h03 HE | Source: Dignity Sciences Limited

DS107G-01 - Successful Completion of Phase I Oral DGLA Clinical Trial

DUBLIN, Ireland, July 30, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Dignity Sciences Limited, a privately held biopharmaceutical company, today announced the successful completion of a Phase I trial with...
08 juil. 2014 02h03 HE | Source: Dignity Sciences Limited

DS107E-02 - Positive Phase II Results in Atopic Dermatitis

DUBLIN, Ireland, July 8, 2014 (GLOBE NEWSWIRE) -- via PRWEB - Dignity Sciences Limited, a privately held biopharmaceutical company, today announced positive Phase II results for DS107E (DGLA cream),...